ADHD Medication Shortage UK: Could the Iran War Make It Worse?

You need to call six pharmacies. You need to chase your GP. You need to research whether your brand has an equivalent alternative, and what "modified-release" actually means, and whether your prescription has already expired because it's been 28 days and you still haven't found stock.

You need to do all of this with the brain that doesn't have the medication.

That's the reality of the UK's ADHD medication shortage — a crisis that's been grinding on since at least late 2023. And now, with the conflict in the Middle East closing one of the world's most critical shipping routes, it could be about to get worse.

What's happening to UK medicine supplies right now?

The closure of the Strait of Hormuz has disrupted approximately 75% of the UK's medicine imports, with NHS England's chief executive warning on 31 March 2026 that some medical supplies could run out within days.

Four weeks into the Iran conflict, the shipping corridor that carries a fifth of the world's oil and a significant share of global pharmaceutical trade has effectively shut down. Commercial traffic through the Strait has dropped roughly 90%.

NHS England chief executive Sir Jim Mackey told LBC Radio on 31 March that he was "really worried" about supply shocks. When asked which supplies were most at risk, his answer was blunt: everything. When pressed on whether some items had only weeks of stock left, he confirmed it could be days for certain products.

Pharmacies across the UK are already reporting what Henry Gregg, chief executive of the National Pharmacy Association, called "disturbing spikes in prices." These price spikes matter because they're an early warning sign: when the cost of a drug rises faster than the amount the NHS reimburses pharmacies for dispensing it, the government has to issue what's called a "price concession" — essentially agreeing to pay the higher market rate. Without these concessions, pharmacies lose money on every prescription they fill and may stop stocking the drug entirely. The Department of Health has issued what's been described as an unprecedented number of these concessions in recent weeks.

The UK government's position is that there are currently no confirmed shortages directly caused by the conflict. But that careful wording — "directly caused" — sits awkwardly against the NHS chief executive's public warning, and against what supply chain experts and pharmacy leaders are seeing on the ground. David Weeks, director of supply chain risk management at Moody's, was less guarded. He described the situation as "the perfect storm."

Why is ADHD medication especially vulnerable?

ADHD medications face a triple vulnerability: a shortage that's been running since at least late 2023, controlled drug restrictions that prevent easy stockpiling or substitution, and heavy dependence on Indian manufacturing that is now directly affected by the Hormuz closure.

If you've been struggling to get your prescription filled, you already know this isn't new. The UK's ADHD medication shortage became official in September 2023 when the Department of Health issued a National Patient Safety Alert — a formal warning to the entire health system that supply of methylphenidate, lisdexamfetamine (sold as Elvanse), and guanfacine (sold as Intuniv, a non-stimulant used when stimulants aren't suitable or tolerated) had been seriously disrupted. That alert has never been fully lifted. Stock issues were reported earlier in 2023, and some patients would say the problems started before that.

As of early 2026, methylphenidate prolonged-release tablets remain in limited supply, Elvanse is constrained at certain strengths, and guanfacine 2mg and 3mg tablets are out of stock entirely. For up-to-date information on which specific medications and strengths are currently available, MediWatch UK maintains the most comprehensive tracker.

A November 2023 survey by the charity ADHD UK found that only 8% of the 1,054 patients surveyed had maintained uninterrupted access to their medication since the shortage began. 70% were rationing — taking lower doses or skipping days to make their supply last. 27% received no medication at all during the worst periods.

Here's what makes ADHD medications harder to fix than other shortages. Methylphenidate and lisdexamfetamine are Schedule 2 controlled drugs — the same legal category as morphine. That means the Home Office controls how much can be manufactured and imported into the UK. Scaling up production takes 12 to 18 months minimum. Your prescription is only valid for 28 days with a maximum 30-day supply, and if you can't fill it in time, it simply expires. Your pharmacist can't give you an emergency supply in most circumstances.

And the usual safety valve doesn't work here either. When other drugs are in short supply, the government can issue a "Serious Shortage Protocol" — an SSP — which allows pharmacists to substitute a different strength or brand without going back to your prescriber. It's a shortcut that saves time. But in January 2025, Health Minister Karin Smyth confirmed that SSPs are "not suitable" for ADHD medications. The controlled drug status, the bioequivalence issues between brands, the complexity of the patients — none of it fits the SSP model.

The system designed to control these drugs is the same system that makes it almost impossible to respond when supply breaks down.

How does a war in the Middle East affect your prescription?

India manufactures roughly a third of the UK's generic medicines — and a significant share of the active ingredients in branded ADHD drugs too — while depending on the Strait of Hormuz for up to half of its crude oil imports, meaning the raw materials, energy, and shipping routes behind your medication are all under strain at once.

This is the bit that sounds abstract until you trace it backwards from your pharmacy shelf.

From the Strait of Hormuz to your pharmacy shelf

China

Starting materials

→

India

API manufacturing

⚠→

Hormuz

90% disrupted

⚠→

🚢

Shipping

+2 wks rerouted

→

UK Pharmacy

Your prescription

The active ingredients in your Elvanse, your Concerta, your methylphenidate — the actual chemical compounds, called APIs (active pharmaceutical ingredients) — are manufactured predominantly in India and China. This is true for both generic and branded medications. Even when the final tablet is formulated and packaged in Europe (Concerta XL, for instance, is made by Janssen in Belgium; Elvanse by Takeda, headquartered in Japan), the raw ingredients still overwhelmingly come from Indian and Chinese suppliers. The vulnerability isn't where the pill is pressed. It's where the chemistry starts.

Indian pharmaceutical companies import almost 70% of their starting materials from China. Those materials are often routed through Gulf logistics hubs before reaching Indian factories. That route is now disrupted.

India depends on imported crude oil for its energy and its petrochemical industry. Oil prices have already spiked roughly 74%, making every stage of manufacturing more expensive for drugs that already run on what Medicines UK chief executive Mark Samuels called "razor-thin margins."

Then there's the shipping. Finished medicines heading from India to the UK via Gulf routes are being rerouted around the Cape of Good Hope, adding approximately two weeks to delivery times. Air freight costs have doubled. Gulf airports that served as key pharmaceutical transit hubs have reduced or shut down operations.

And then there's the human end of all of this.

During the worst of the shortage in 2023 and 2024, one Mumsnet user wrote that she had "telephoned over 150 chemists" trying to find stock, calling it "hell." Another described a three-hour round trip after the Boots stock checker showed availability, only to arrive and find the information wasn't up to date. These aren't new stories — they've been playing out for over two years — but the Iran crisis now threatens to make them worse and more widespread.

"Without medication I'm excruciatingly tired, barely able to leave the house let alone do my work, run a household and run up and down the country in search for a medication."— Mumsnet user, ADHD medication shortage thread, 2024

The executive function you need to navigate a medication shortage is exactly what the medication gives you. Forum after forum, the same pattern: people without their ADHD medication trying to manage the bureaucratic obstacle course of finding their ADHD medication. A 2025 study published in Frontiers in Pharmacology, analysing hundreds of patient posts, found these tasks were "often insurmountable." The controlled drug prescription system compounds it: unfilled prescriptions expire after 28 days, forcing you to start the entire process again.

And the psychological toll goes beyond the practical. Anxiety about whether you'll be able to get your medication next month. Depression when you can't function the way you could last week. Loss of confidence at work. Strain on relationships when the people around you don't understand why you've suddenly changed. ADHD UK has noted that people with ADHD already have a 30% higher risk of suicide — and medication withdrawal without support creates acute risk. The mental health impact of this shortage is real, documented, and largely invisible in the headlines.

What about HRT? The perimenopause double hit

Women in perimenopause with ADHD face a compounded risk: both ADHD medication and HRT supply chains run through the same disrupted routes, while declining oestrogen actively worsens ADHD symptoms by reducing the brain's dopamine availability.

If you're reading this and you're also on HRT, I want you to know that someone sees the full picture.

This isn't two separate problems that happen to affect the same person. It's one biological reality. Oestrogen directly supports your dopamine system — the same system your ADHD medication targets. It helps produce dopamine, helps release it, slows its breakdown, and makes your brain more responsive to it. When oestrogen drops during perimenopause, your existing dopamine deficit gets worse. Your ADHD symptoms intensify. And your medication may become less effective at the very moment you need it most.

A 2025 population-based study published in PMC found that women with ADHD scored higher on every measured dimension of perimenopausal symptoms — psychological, physical, and urogenital — compared to women without ADHD. Women with ADHD reported their worst symptoms at 35 to 39, a full decade earlier than neurotypical women.

Many women are first diagnosed with ADHD during perimenopause, when the hormonal safety net drops and the coping strategies of a lifetime stop working. Dr Louise Newson, the UK's leading menopause specialist, has said that many women "only come to learn about having ADHD when their symptoms worsen due to a particular stressor such as entering perimenopause."

"I am currently on my fourth type of ADHD meds and my third type of HRT due to shortages."— Margaret Reed Roberts, diagnosed with ADHD at 47 during perimenopause, Balance platform

HRT supply chains are vulnerable through the same pathways. The active ingredients in oestrogen patches and progesterone capsules — estradiol and progesterone — are manufactured by suppliers concentrated in India and China, dependent on the same petrochemical inputs, energy costs, and shipping routes. The UK has experienced rolling HRT shortages since 2018, peaking in 2022 when the government appointed an HRT "Tsar" to manage the crisis.

Nobody in the mainstream press is connecting these two shortages for this audience. If you're a woman in midlife with ADHD and you're struggling to access both your ADHD meds and your HRT, the biology of what's happening to you is not in your head. It's real. It's documented. And you deserve support that understands the whole picture.

What can you do if you can't get your medication?

Start with your pharmacist, try multiple pharmacies using online stock checkers, contact your prescriber about alternatives, and know the safety rules — especially that guanfacine must never be stopped suddenly.

This is your crisis toolkit. Not a permanent fix — a way through the gap.

What can you do when the system keeps failing you?

Building strategies that work alongside medication — structured routines, movement, understanding your own brain — means that when the supply chain breaks, you have something to fall back on.

I want to be honest about something. Medication matters. For many people with ADHD, it's the single most effective intervention available. I'm not going to pretend otherwise, and I'm not going to suggest that a good morning routine replaces methylphenidate.

But I've watched this shortage play out for over two years now. And the women who cope best during the gaps are the ones who've already built something underneath the medication. Not instead of it. Alongside it.

The evidence supports this. A 2025 meta-analysis of 37 clinical trials found that CBT adapted specifically for ADHD — not generic CBT, which can actually make things worse if it's not designed for how ADHD brains work — significantly reduced symptoms in both the short and long term. It's particularly helpful for the anxiety and low mood that medication gaps can trigger.

Physical exercise provides an immediate, accessible dopamine boost through the same brain pathways that stimulant medication targets. Meta-analyses show that even a single 20 to 30 minute session of moderate aerobic activity — a brisk walk, a bike ride, a swim — can measurably improve attention and executive function for several hours afterwards. It's not a replacement for medication. But on the days when you don't have it, it's one of the most evidence-based things you can do.

NICE clinical guidance recommends psychological and behavioural support at every stage of ADHD treatment, not just as a fallback when medication isn't available.

But the strategies that actually stick aren't generic advice from a list. They're the ones built around your brain. Understanding why you procrastinate on that specific task. Knowing which environments help you focus and which drain you. Having a plan for the days when your brain simply will not cooperate — not "try harder," but something you've already figured out works for you.

That's what coaching does. Not replacing medication. Not pretending the system isn't broken. Building the part that doesn't depend on a supply chain — so that when the system fails you again (and it will), you're not starting from nothing.

You shouldn't have to do it alone.

Book a free discovery call → · Try the ADHD Wheel of Life →